9DO Stock Overview
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Glow Lifetech Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.04 |
| 52 Week High | CA$0.058 |
| 52 Week Low | CA$0.012 |
| Beta | 2.53 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | -27.27% |
| 33 Year Change | -72.79% |
| 5 Year Change | n/a |
| Change since IPO | -89.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9DO | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 23.1% | 0.6% | 1.5% |
| 1Y | -27.3% | -14.5% | 5.9% |
Return vs Industry: 9DO underperformed the German Pharmaceuticals industry which returned -15.2% over the past year.
Return vs Market: 9DO underperformed the German Market which returned 5.2% over the past year.
Price Volatility
| 9DO volatility | |
|---|---|
| 9DO Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 9DO's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 9DO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Rob Carducci | glowlifetech.com |
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products. The company exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron.
Glow Lifetech Corp. Fundamentals Summary
| 9DO fundamental statistics | |
|---|---|
| Market cap | €2.43m |
| Earnings (TTM) | -€1.01m |
| Revenue (TTM) | €126.99k |
42.4x
P/S Ratio-5.4x
P/E RatioIs 9DO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9DO income statement (TTM) | |
|---|---|
| Revenue | CA$192.04k |
| Cost of Revenue | CA$79.00k |
| Gross Profit | CA$113.04k |
| Other Expenses | CA$1.63m |
| Earnings | -CA$1.52m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 58.86% |
| Net Profit Margin | -792.23% |
| Debt/Equity Ratio | -313.0% |
How did 9DO perform over the long term?
See historical performance and comparison